Immediate Impact
2 from Science/Nature 47 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Works of Paulo Caldeira being referenced
Can we optimize the CEA as a response marker in rectal cancer?
2020
Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point‐of‐care quantitative test with two established ELISA assays
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Paulo Caldeira | 67 | 96 | 126 | 19 | 236 | |
| Justin Côté-Daigneault | 92 | 140 | 129 | 17 | 299 | |
| Satoshi Motoya | 94 | 121 | 174 | 12 | 265 | |
| Tomomi Yukawa | 70 | 100 | 133 | 17 | 228 | |
| Sameer Al Awadhi | 124 | 110 | 145 | 25 | 272 | |
| Zhihua Ran | 66 | 94 | 138 | 25 | 265 | |
| Arnold Stronkhorst | 93 | 87 | 153 | 21 | 295 | |
| Claire Bewshea | 53 | 93 | 154 | 26 | 204 | |
| Anneline Cremer | 71 | 125 | 157 | 20 | 210 | |
| Ilia Tikhonov | 87 | 131 | 167 | 13 | 269 | |
| Joana Roseira | 49 | 59 | 84 | 22 | 163 |
All Works
Loading papers...